|COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring.|
Engineering and medicine: Opportunities in type 1 diabetes
If you have a question about this talk, please contact Dr Jason Z JIANG.
The development of the artificial pancreas is underway with considerable stakeholders input and industry interest. Aimed to treat type 1 diabetes of all ages from early childhood to maturity, the artificial pancreas consists of a continuous glucose meter, control algorithm and an insulin pump. Significant life sciences opportunities exist to complement the clinical work and accelerate research progress and commercialisation of the artificial pancreas.
This talk is part of the CUED Control Group Seminars series.
This talk is included in these lists:
Note that ex-directory lists are not shown.
Other listsSustainability in the Built Environment (GreenBRIDGE) The Encyclopaedia of Literature in African Languages Set Theory Seminar
Other talksMuslims under Nazi Rule, 1941-1945 STFC collaborative R&D funding Collective dynamics in confined bacterial suspensions Traffic control for immune receptors Alterations of brain function in pre-dementia Alzheimer’s disease: implications for early diagnosis How and why cells switch off clathrin-mediated endocytosis during mitosis